STX6 and neurodegenerative disease: Finally, the pleiotropic role of syntaxin-6 across multiple neurodegenerative diseases, including PSP and AD, raises the potential that STX6-targeting therapies could have wider applicability to other neurode-generative diseases, warranting further investigation.